Phase II trial of the CDK4 inhibitor PD0332991 in CDK4-amplified liposarcoma Meeting Abstract

  


Authors: Dickson, M. A.; Keohan, M. L.; Tap, W. D.; Antonescu, C.; Landa, J.; Qin, L. X.; Dohrenwend, E. G.; Rathbone, D.; Ustoyev, Y.; Condy, M. M.; Singer, S.; Schwartz, G. K.
Abstract Title: Phase II trial of the CDK4 inhibitor PD0332991 in CDK4-amplified liposarcoma
Meeting Title: 48th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 30
Issue: 15 Suppl.
Meeting Dates: 2012 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2012-05-20
Language: English
ACCESSION: WOS:000318009800032
PROVIDER: wos
DOI: 10.1200/jco.2012.30.15_suppl.10002
Notes: Meeting Abstract: 10002 -- Source: Wos
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Gary Schwartz
    385 Schwartz
  2. Cristina R Antonescu
    902 Antonescu
  3. Jonathan Landa
    37 Landa
  4. Li-Xuan Qin
    193 Qin
  5. Mary Louise Keohan
    126 Keohan
  6. Samuel Singer
    337 Singer
  7. Mark Andrew Dickson
    172 Dickson
  8. Mercedes M Condy
    19 Condy
  9. William Douglas Tap
    377 Tap
  10. Dustin Daniel Rathbone
    3 Rathbone
  11. Yelena Ustoyev
    6 Ustoyev
  12. Eric Gerard Dohrenwend
    1 Dohrenwend
Related MSK Work